Cholesterol emboli syndrome natural history, complications and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
Overview
Common complications of Cholesterol emboli syndrome include atheroembolic renal disease, acute kidney injury, chronic kidney disease, myocardial infarction, cerebrovascular accident bowel ischemia, liver failure, end organ damage and death. Prognosis is generally poor, and the incidence of mortality among patients with Cholesterol emboli syndrome is approximately 63-80 %.
Natural History, Complications and Prognosis
- Common complications of Cholesterol emboli syndrome include atheroembolic renal disease, acute kidney injury, chronic kidney disease, myocardial infarction, cerebrovascular accident bowel ischemia, liver failure, end organ damage and death. [1][2]
- Prognosis is generally poor, and the incidence of mortality among patients with Cholesterol emboli syndrome is approximately 63-80 %.[1][3]
References
- ↑ 1.0 1.1 Agrawal, Akanksha; Ziccardi, Mary Rodriguez; Witzke, Christian; Palacios, Igor; Rangaswami, Janani (2018). “Cholesterol embolization syndrome: An under-recognized entity in cardiovascular interventions”. Journal of Interventional Cardiology. 31 (3): 407–415. doi:10.1111/joic.12483. ISSN 0896-4327.
- ↑ Ozkok, Abdullah (2019). “
Cholesterol-embolization syndrome: current perspectives
“. Vascular Health and Risk Management. Volume 15: 209–220. doi:10.2147/VHRM.S175150. ISSN 1178-2048. - ↑ Fine, Michael J.; Kapoor, Wishwa; Falanga, Vincent (2016). “Cholesterol Crystal Embolization: A Review of 221 Cases in the English Literature”. Angiology. 38 (10): 769–784. doi:10.1177/000331978703801007. ISSN 0003-3197.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH